Cancer Res Treat.  2025 Apr;57(2):331-338. 10.4143/crt.2025.263.

Prediction of Cancer Incidence and Mortality in Korea, 2025

• Jung KW
• Kang MJ
• Park EH
• Yun EH
• Kim HJ
• Kim JE
• Kong HJ
• Choi KS
• Yang HK

• KMID: 2566852
• DOI: http://doi.org/10.4143/crt.2025.263

Abstract

Purpose
This study aimed to project cancer incidence and mortality for 2025 to estimate Korea’s current cancer burden.
Materials and Methods
Cancer incidence data from 1999 to 2022 were obtained from the Korea National Cancer Incidence Database, while cancer mortality data from 1993 to 2023 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2025. A joinpoint regression model was applied to identify significant changes in trends, using only the most recent trend data for predictions.
Results
A total of 304,754 new cancer cases and 84,019 cancer deaths are expected in Korea in 2025. The most commonly diagnosed cancer is projected to be thyroid cancer, followed by the colorectal, lung, breast, prostate and stomach cancers. These six cancers are expected to account for 63.8% of the total cancer burden. Lung cancer is expected to be the leading cause of cancer-related deaths, followed by liver, colorectal, pancreatic, stomach, and gallbladder cancers, together comprising 66.6% of total cancer deaths.
Conclusion
The increasing incidence of female breast cancer and the rise in prostate and pancreatic cancers are expected to continue. As aging accelerates, cancer commonly found in older adults are projected to rise significantly.

Keyword

IIncidence; Mortality; Neoplasms; Forecasting; Korea; 2025

Figure

• 

  Fig. 1. The 10 leading types of estimated new cancer cases and deaths by sex in 2025. (A) Estimated new cases. (B) Estimated deaths.

• 

  Fig. 2. Projected age-specific incidences of major cancers during 2025 in Korea. (A) Men. (B) Women.

• 

  Fig. 3. Projected age-specific mortality rates of major cancers during 2025 in Korea. (A) Men. (B) Women.

Reference

References

1. Statistics Korea [Internet]. Statistics Korea; 2025 [cited 2025 Feb 10]. Available from: http://kosis.kr.

2. Park EH, Jung KW, Park NJ, Kang MJ, Yun EH, Kim HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2021. Cancer Res Treat. 2024; 56:357–71.

3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999-2001: first result using the National Cancer Incidence Database. Cancer Res Treat. 2005; 37:325–31.

4. World Health Organization. International Classification of Diseases for Oncology (ICD-O), 3rd ed., 2nd rev. [Internet]. World Health Organization; 2019 [cited 2025 Feb 10]. Available from: https://iris.who.int/handle/10665/96612.

5. World Health Organization. International statistical classification of diseases and related health problems, 10th rev. [Internet]. World Health Organization; 2009 [cited 2025 Feb 10]. Available from: https://iris.who.int/handle/10665/44081.

6. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. IARC Scientific Publication No. 95. IARC Press; 1991. p. 126-58.

7. National Cancer Institute. Joinpoint regression program, version 5.0.2.2 [Internet]. National Cancer Institute; 2025 [cited 2025 Feb 10]. Available from: http://surveillance.cancer.gov/joinpoint/.

8. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Tohoku University School of Medicine;1960.